Cargando…
Tu1551: PATIENTS WITH INFLAMMATORY BOWEL DISEASES HAVE IMPAIRED ANTIBODY PRODUCTION AFTER ANTI-SARS-COV-2 VACCINATION, ESPECIALLY THOSE ON ANTI-TNFα OR COMBINATION TREATMENT OF BIOLOGICS PLUS IMMUNOMODULATORS: RESULTS FROM A PANHELLENIC REGISTRY
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AGA Institute. Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212535/ http://dx.doi.org/10.1016/S0016-5085(22)62389-8 |
| _version_ | 1784730619772665856 |
|---|---|
| author | Zacharopoulou, Eirini Orfanoudaki, Eleni Kitsou, Vassiliki Tzouvala, Maria Tribonias, George Mantzaris, Gerassimos J. Viazis, Nikos Christidou, Angeliki Georgiadi, Tereza Karmiris, Konstantinos Theodoropoulou, Angeliki Tsafaridou, Maria Michopoulos, Spyridon Zampeli, Evanthia Papathanasiou, Evgenia Michalopoulos, Georgios Tigkas, Stefanos Karatzas, Pantelis Laoudi, Effrosyni Liatsos, Christos Kyriakos, Nikolaos Mylonas, Iordanis Theocharis, Georgios J. Kafentzi, Theodora Koutroubakis, Ioannis E. Bamias, Giorgos |
| author_facet | Zacharopoulou, Eirini Orfanoudaki, Eleni Kitsou, Vassiliki Tzouvala, Maria Tribonias, George Mantzaris, Gerassimos J. Viazis, Nikos Christidou, Angeliki Georgiadi, Tereza Karmiris, Konstantinos Theodoropoulou, Angeliki Tsafaridou, Maria Michopoulos, Spyridon Zampeli, Evanthia Papathanasiou, Evgenia Michalopoulos, Georgios Tigkas, Stefanos Karatzas, Pantelis Laoudi, Effrosyni Liatsos, Christos Kyriakos, Nikolaos Mylonas, Iordanis Theocharis, Georgios J. Kafentzi, Theodora Koutroubakis, Ioannis E. Bamias, Giorgos |
| author_sort | Zacharopoulou, Eirini |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9212535 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | AGA Institute. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92125352022-06-22 Tu1551: PATIENTS WITH INFLAMMATORY BOWEL DISEASES HAVE IMPAIRED ANTIBODY PRODUCTION AFTER ANTI-SARS-COV-2 VACCINATION, ESPECIALLY THOSE ON ANTI-TNFα OR COMBINATION TREATMENT OF BIOLOGICS PLUS IMMUNOMODULATORS: RESULTS FROM A PANHELLENIC REGISTRY Zacharopoulou, Eirini Orfanoudaki, Eleni Kitsou, Vassiliki Tzouvala, Maria Tribonias, George Mantzaris, Gerassimos J. Viazis, Nikos Christidou, Angeliki Georgiadi, Tereza Karmiris, Konstantinos Theodoropoulou, Angeliki Tsafaridou, Maria Michopoulos, Spyridon Zampeli, Evanthia Papathanasiou, Evgenia Michalopoulos, Georgios Tigkas, Stefanos Karatzas, Pantelis Laoudi, Effrosyni Liatsos, Christos Kyriakos, Nikolaos Mylonas, Iordanis Theocharis, Georgios J. Kafentzi, Theodora Koutroubakis, Ioannis E. Bamias, Giorgos Gastroenterology AGA Abstracts AGA Institute. Published by Elsevier Inc. 2022-05 2022-06-16 /pmc/articles/PMC9212535/ http://dx.doi.org/10.1016/S0016-5085(22)62389-8 Text en Copyright © 2022 AGA Institute. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | AGA Abstracts Zacharopoulou, Eirini Orfanoudaki, Eleni Kitsou, Vassiliki Tzouvala, Maria Tribonias, George Mantzaris, Gerassimos J. Viazis, Nikos Christidou, Angeliki Georgiadi, Tereza Karmiris, Konstantinos Theodoropoulou, Angeliki Tsafaridou, Maria Michopoulos, Spyridon Zampeli, Evanthia Papathanasiou, Evgenia Michalopoulos, Georgios Tigkas, Stefanos Karatzas, Pantelis Laoudi, Effrosyni Liatsos, Christos Kyriakos, Nikolaos Mylonas, Iordanis Theocharis, Georgios J. Kafentzi, Theodora Koutroubakis, Ioannis E. Bamias, Giorgos Tu1551: PATIENTS WITH INFLAMMATORY BOWEL DISEASES HAVE IMPAIRED ANTIBODY PRODUCTION AFTER ANTI-SARS-COV-2 VACCINATION, ESPECIALLY THOSE ON ANTI-TNFα OR COMBINATION TREATMENT OF BIOLOGICS PLUS IMMUNOMODULATORS: RESULTS FROM A PANHELLENIC REGISTRY |
| title | Tu1551: PATIENTS WITH INFLAMMATORY BOWEL DISEASES HAVE IMPAIRED ANTIBODY PRODUCTION AFTER ANTI-SARS-COV-2 VACCINATION, ESPECIALLY THOSE ON ANTI-TNFα OR COMBINATION TREATMENT OF BIOLOGICS PLUS IMMUNOMODULATORS: RESULTS FROM A PANHELLENIC REGISTRY |
| title_full | Tu1551: PATIENTS WITH INFLAMMATORY BOWEL DISEASES HAVE IMPAIRED ANTIBODY PRODUCTION AFTER ANTI-SARS-COV-2 VACCINATION, ESPECIALLY THOSE ON ANTI-TNFα OR COMBINATION TREATMENT OF BIOLOGICS PLUS IMMUNOMODULATORS: RESULTS FROM A PANHELLENIC REGISTRY |
| title_fullStr | Tu1551: PATIENTS WITH INFLAMMATORY BOWEL DISEASES HAVE IMPAIRED ANTIBODY PRODUCTION AFTER ANTI-SARS-COV-2 VACCINATION, ESPECIALLY THOSE ON ANTI-TNFα OR COMBINATION TREATMENT OF BIOLOGICS PLUS IMMUNOMODULATORS: RESULTS FROM A PANHELLENIC REGISTRY |
| title_full_unstemmed | Tu1551: PATIENTS WITH INFLAMMATORY BOWEL DISEASES HAVE IMPAIRED ANTIBODY PRODUCTION AFTER ANTI-SARS-COV-2 VACCINATION, ESPECIALLY THOSE ON ANTI-TNFα OR COMBINATION TREATMENT OF BIOLOGICS PLUS IMMUNOMODULATORS: RESULTS FROM A PANHELLENIC REGISTRY |
| title_short | Tu1551: PATIENTS WITH INFLAMMATORY BOWEL DISEASES HAVE IMPAIRED ANTIBODY PRODUCTION AFTER ANTI-SARS-COV-2 VACCINATION, ESPECIALLY THOSE ON ANTI-TNFα OR COMBINATION TREATMENT OF BIOLOGICS PLUS IMMUNOMODULATORS: RESULTS FROM A PANHELLENIC REGISTRY |
| title_sort | tu1551: patients with inflammatory bowel diseases have impaired antibody production after anti-sars-cov-2 vaccination, especially those on anti-tnfα or combination treatment of biologics plus immunomodulators: results from a panhellenic registry |
| topic | AGA Abstracts |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212535/ http://dx.doi.org/10.1016/S0016-5085(22)62389-8 |
| work_keys_str_mv | AT zacharopouloueirini tu1551patientswithinflammatoryboweldiseaseshaveimpairedantibodyproductionafterantisarscov2vaccinationespeciallythoseonantitnfaorcombinationtreatmentofbiologicsplusimmunomodulatorsresultsfromapanhellenicregistry AT orfanoudakieleni tu1551patientswithinflammatoryboweldiseaseshaveimpairedantibodyproductionafterantisarscov2vaccinationespeciallythoseonantitnfaorcombinationtreatmentofbiologicsplusimmunomodulatorsresultsfromapanhellenicregistry AT kitsouvassiliki tu1551patientswithinflammatoryboweldiseaseshaveimpairedantibodyproductionafterantisarscov2vaccinationespeciallythoseonantitnfaorcombinationtreatmentofbiologicsplusimmunomodulatorsresultsfromapanhellenicregistry AT tzouvalamaria tu1551patientswithinflammatoryboweldiseaseshaveimpairedantibodyproductionafterantisarscov2vaccinationespeciallythoseonantitnfaorcombinationtreatmentofbiologicsplusimmunomodulatorsresultsfromapanhellenicregistry AT triboniasgeorge tu1551patientswithinflammatoryboweldiseaseshaveimpairedantibodyproductionafterantisarscov2vaccinationespeciallythoseonantitnfaorcombinationtreatmentofbiologicsplusimmunomodulatorsresultsfromapanhellenicregistry AT mantzarisgerassimosj tu1551patientswithinflammatoryboweldiseaseshaveimpairedantibodyproductionafterantisarscov2vaccinationespeciallythoseonantitnfaorcombinationtreatmentofbiologicsplusimmunomodulatorsresultsfromapanhellenicregistry AT viazisnikos tu1551patientswithinflammatoryboweldiseaseshaveimpairedantibodyproductionafterantisarscov2vaccinationespeciallythoseonantitnfaorcombinationtreatmentofbiologicsplusimmunomodulatorsresultsfromapanhellenicregistry AT christidouangeliki tu1551patientswithinflammatoryboweldiseaseshaveimpairedantibodyproductionafterantisarscov2vaccinationespeciallythoseonantitnfaorcombinationtreatmentofbiologicsplusimmunomodulatorsresultsfromapanhellenicregistry AT georgiaditereza tu1551patientswithinflammatoryboweldiseaseshaveimpairedantibodyproductionafterantisarscov2vaccinationespeciallythoseonantitnfaorcombinationtreatmentofbiologicsplusimmunomodulatorsresultsfromapanhellenicregistry AT karmiriskonstantinos tu1551patientswithinflammatoryboweldiseaseshaveimpairedantibodyproductionafterantisarscov2vaccinationespeciallythoseonantitnfaorcombinationtreatmentofbiologicsplusimmunomodulatorsresultsfromapanhellenicregistry AT theodoropoulouangeliki tu1551patientswithinflammatoryboweldiseaseshaveimpairedantibodyproductionafterantisarscov2vaccinationespeciallythoseonantitnfaorcombinationtreatmentofbiologicsplusimmunomodulatorsresultsfromapanhellenicregistry AT tsafaridoumaria tu1551patientswithinflammatoryboweldiseaseshaveimpairedantibodyproductionafterantisarscov2vaccinationespeciallythoseonantitnfaorcombinationtreatmentofbiologicsplusimmunomodulatorsresultsfromapanhellenicregistry AT michopoulosspyridon tu1551patientswithinflammatoryboweldiseaseshaveimpairedantibodyproductionafterantisarscov2vaccinationespeciallythoseonantitnfaorcombinationtreatmentofbiologicsplusimmunomodulatorsresultsfromapanhellenicregistry AT zampelievanthia tu1551patientswithinflammatoryboweldiseaseshaveimpairedantibodyproductionafterantisarscov2vaccinationespeciallythoseonantitnfaorcombinationtreatmentofbiologicsplusimmunomodulatorsresultsfromapanhellenicregistry AT papathanasiouevgenia tu1551patientswithinflammatoryboweldiseaseshaveimpairedantibodyproductionafterantisarscov2vaccinationespeciallythoseonantitnfaorcombinationtreatmentofbiologicsplusimmunomodulatorsresultsfromapanhellenicregistry AT michalopoulosgeorgios tu1551patientswithinflammatoryboweldiseaseshaveimpairedantibodyproductionafterantisarscov2vaccinationespeciallythoseonantitnfaorcombinationtreatmentofbiologicsplusimmunomodulatorsresultsfromapanhellenicregistry AT tigkasstefanos tu1551patientswithinflammatoryboweldiseaseshaveimpairedantibodyproductionafterantisarscov2vaccinationespeciallythoseonantitnfaorcombinationtreatmentofbiologicsplusimmunomodulatorsresultsfromapanhellenicregistry AT karatzaspantelis tu1551patientswithinflammatoryboweldiseaseshaveimpairedantibodyproductionafterantisarscov2vaccinationespeciallythoseonantitnfaorcombinationtreatmentofbiologicsplusimmunomodulatorsresultsfromapanhellenicregistry AT laoudieffrosyni tu1551patientswithinflammatoryboweldiseaseshaveimpairedantibodyproductionafterantisarscov2vaccinationespeciallythoseonantitnfaorcombinationtreatmentofbiologicsplusimmunomodulatorsresultsfromapanhellenicregistry AT liatsoschristos tu1551patientswithinflammatoryboweldiseaseshaveimpairedantibodyproductionafterantisarscov2vaccinationespeciallythoseonantitnfaorcombinationtreatmentofbiologicsplusimmunomodulatorsresultsfromapanhellenicregistry AT kyriakosnikolaos tu1551patientswithinflammatoryboweldiseaseshaveimpairedantibodyproductionafterantisarscov2vaccinationespeciallythoseonantitnfaorcombinationtreatmentofbiologicsplusimmunomodulatorsresultsfromapanhellenicregistry AT mylonasiordanis tu1551patientswithinflammatoryboweldiseaseshaveimpairedantibodyproductionafterantisarscov2vaccinationespeciallythoseonantitnfaorcombinationtreatmentofbiologicsplusimmunomodulatorsresultsfromapanhellenicregistry AT theocharisgeorgiosj tu1551patientswithinflammatoryboweldiseaseshaveimpairedantibodyproductionafterantisarscov2vaccinationespeciallythoseonantitnfaorcombinationtreatmentofbiologicsplusimmunomodulatorsresultsfromapanhellenicregistry AT kafentzitheodora tu1551patientswithinflammatoryboweldiseaseshaveimpairedantibodyproductionafterantisarscov2vaccinationespeciallythoseonantitnfaorcombinationtreatmentofbiologicsplusimmunomodulatorsresultsfromapanhellenicregistry AT koutroubakisioannise tu1551patientswithinflammatoryboweldiseaseshaveimpairedantibodyproductionafterantisarscov2vaccinationespeciallythoseonantitnfaorcombinationtreatmentofbiologicsplusimmunomodulatorsresultsfromapanhellenicregistry AT bamiasgiorgos tu1551patientswithinflammatoryboweldiseaseshaveimpairedantibodyproductionafterantisarscov2vaccinationespeciallythoseonantitnfaorcombinationtreatmentofbiologicsplusimmunomodulatorsresultsfromapanhellenicregistry |